Search

Author/Creator Trinh, Huy

2. IDDF2019-ABS-0169 A phase 3 study comparing switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) with continued TDF treatment in virologically-suppressed patients with chronic hepatitis B (CHB): week 48 efficacy and safety results. (June 2019)

Authors:
Lik Yuen Chan, Henry; Lampertico, Pietro; Buti, Maria; Fung, Scott; Ahn, Sang Hoon; Chuang, Wan-Long; Tak, Won Young; Ramji, Alnoor; Chen, Chi-Yi; Tam, Edward; Bae, Ho; Ma, Xiaoli; Flaherty, John; Gaggar, Anuj; Lau, Audrey; Feierbach, Becket; Wu, George; Suri, Vithika; Subramanian, Mani; Trinh, Huy
Journal:
Gut
Issue:
Volume 68(2019)Supplement 1
Page Start:
A142
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. IDDF2020-ABS-0058 48-week safety and efficacy of switching to tenofovir alafenamide (TAF) from tenofovir disoproxil fumarate (TDF) in chronic HBV asian patients with TDF risk factors (RF). (18th November 2020)

Authors:
Ahn, Sang Hoon; Kao, Jia-Horng; Hann, Hie-Won; Scott, Fung; Trinh, Huy; Nguyen, Tuan Trong; Paik, Seung Woon; Gaggar, Anuj; Flaherty, John; Yee, Leland; Jump, Belinda; Sethi, Shalini; Wu, George; Kwan Chan, Carol Yee
Journal:
Gut
Issue:
Volume 69(2020)Supplement 2
Page Start:
A73
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B. (17th May 2021)

Authors:
Hsu, Yao-Chun; Yeh, Ming-Lun; Wong, Grace Lai-Hung; Chen, Chien-Hung; Peng, Cheng-Yuan; Buti, Maria; Enomoto, Masaru; Xie, Qing; Trinh, Huy; Preda, Carmen; Liu, Li; Cheung, Ka-Shing; Yeo, Yee Hui; Hoang, Joseph; Huang, Chung-Feng; Riveiro-Barciela, Mar; Kozuka, Ritsuzo; Istratescu, Doina; Tsai, P...
Journal:
Journal of infectious diseases
Issue:
Volume 224:Number 11(2021)
Page Start:
1890
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study. (September 2016)

Authors:
Ahn, Joseph; Lim, Joseph K; Lee, Hannah M; Lok, Anna S; Nguyen, Mindie; Pan, Calvin Q; Mannalithara, Ajitha; Te, Helen; Reddy, Rajender K.; Trinh, Huy; Chu, Danny; Tran, Tram; Lau, Daryl; Leduc, Truong‐Sinh; Min, Albert; Le, Loc Trong; Bae, Ho; Van Tran, Sang; Do, Son; Hann, Hie‐Won L
Journal:
American journal of gastroenterology
Issue:
Volume 111:Number 9(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Poor adherence and low persistency rates for hepatocellular carcinoma surveillance in patients with chronic hepatitis B. Issue 35 (August 2016)

Authors:
Wang, Christina; Chen, Vincent; Vu, Vinh; Le, An; Nguyen, Linda; Zhao, Changqing; Wong, Carrie R.; Nguyen, Nghia; Li, Jiayi; Zhang, Jian; Trinh, Huy; Nguyen, Mindie H.
Other Names:
Adinolfi. Luigi Elio section editor.
Journal:
Medicine
Issue:
Volume 95:Issue 35(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. S1126 Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) in Virally Suppressed Chronic Hepatitis B (CHB) Patients With Hepatic Impairment: Week 48 Results From a Phase 2 Open Label Study. (October 2020)

Authors:
Bae, Ho S.; Lim, Young-Suk; Trinh, Huy; Heo, Jeong; Chuang, Wan-Long; Hui, Aric Josun; Elkhashab, Magdy; Tan, Susanna K.; Mo, Shuyuan; Guion, Matthew; Jump, Belinda; Flaherty, John; Suri, Vithika; Gaggar, Anuj; Owen Tsang, Tak Yin; Andreone, Pietro; Janssen, Harry
Journal:
American journal of gastroenterology
Issue:
Volume 115:Supplement(2020)Advances in Inflammatory Bowel Diseases Annual Meeting Abstracts1
Page Start:
S566
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Sustained virologic response rates in patients with chronic hepatitis C genotype 6 treated with ledipasvir+sofosbuvir or sofosbuvir+velpatasvir. Issue 1 (22nd November 2018)

Authors:
Nguyen, Emily; Trinh, Sam; Trinh, Huy; Nguyen, Huy; Nguyen, Khanh; Do, Aivien; Levitt, Brian; Do, Son; Nguyen, My; Purohit, Treta; Shieh, Eugenie; Nguyen, Mindie H.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 49:Issue 1(2019)
Page Start:
99
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study. (May 2020)

Authors:
Lampertico, Pietro; Buti, Maria; Fung, Scott; Ahn, Sang Hoon; Chuang, Wan-Long; Tak, Won Young; Ramji, Alnoor; Chen, Chi-Yi; Tam, Edward; Bae, Ho; Ma, Xiaoli; Flaherty, John F; Gaggar, Anuj; Lau, Audrey; Liu, Yang; Wu, George; Suri, Vithika; Tan, Susanna K; Subramanian, G Mani; Trinh, Huy
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 5:Number 5(2020)
Page Start:
441
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗